Key points:
- ATAGI advises the following groups should consider a 2023 booster dose if their last COVID-19 vaccine dose or confirmed infection (whichever is the most recent) was 6 months ago or longer, and regardless of the number of prior doses received, based on an individual risk benefit assessment with their immunisation provider.
- All Adults aged 18-64 years without risk factors for severe COVID-19
- Children and adolescents aged 5-17 years who have medical comorbidities that increase their risk of severe COVID-19, or disability with significant or complex health needs.
- ATAGI advises that a booster dose is not recommended at this time for children and adolescents aged under the age of 18 who do not have any risk factors for severe COVID-19.
See pdf:
Please also note that the pharmaceutic drug used to treat C-19 cannot be called vaccine as it does not confer immunity.
See U.S. Supreme Court case from 4th of November 2021:
See Pfizer document leak:
https://phmpt.org/pfizers-documents/
See article of the headline:
On this day 3 years ago Australia’s largest health & legal farces began
Related posts:
Report: Companies Stand to Make Billions Off Coronavirus Booster Shots
Expert Advice: Learn How to Podcast on WordPress.com
Queen Elizabeth Cancels Schedule, Accepts Medical Advice To Rest For Few Days
European Medicines Agency Warns Endless Booster Shots Could Cause “Immune Response” Problems
NHS Removes References to Women From Advice About Menopause
‘If ONE American is killed, I’ll hold YOU responsible’: Trump’s ‘friendly health advice’ to Iran ami...